Prognostic impact of extracranial disease control in HER2+ breast cancer-related brain metastases.
Michele BottossoGaia GriguoloLéa SinoquetMaria Cristina GuarascioVittoria AldegheriFederica MigliettaGrazia VernaciCaterina BarbieriFabio GirardiWilliam JacotValentina GuarneriAmélie DarlixMaria Vittoria DieciPublished in: British journal of cancer (2023)
Extracranial disease control provides independent prognostic information in HER2+ BCBM beyond commonly used prognostic scores.